Meet China’s New Innovators: Haixi Pharma Appoints Beta Pharma Alum To Build Biotech From Scratch
This article was originally published in PharmAsia News
Executive Summary
CEO Jason Kang, former chief scientist at Beta Pharma, is building a pipeline of Class I molecules with experience on what it takes to build a start-up company in China.